Vaxcyte, Inc. PCVX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s common stock, shares issued (in shares)?
- Vaxcyte, Inc. (PCVX) reported common stock, shares issued (in shares) of $144.31M in Q1 2026.
- How has Vaxcyte, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Vaxcyte, Inc.'s common stock, shares issued (in shares) increased by 11.9% year-over-year, from $128.94M to $144.31M.
- What is the long-term trend for Vaxcyte, Inc.'s common stock, shares issued (in shares)?
- Over 2 years (2023 to 2025), Vaxcyte, Inc.'s common stock, shares issued (in shares) has grown at a 17.2% compound annual growth rate (CAGR), from $95.36M to $131.06M.